Sandoz Extends Collaboration Agreement to Drive Cutting-Edge Digital Solutions in Global Fight Against Antimicrobial Resistance (AMR)

• Extending existing master services agreement with Ares Genetics, to develop digital platform for development and life cycle management of antibiotics, to January 31, 2025 • Both parties strengthening focus on antibiotic stewardship and planning to engage in AMR surveillance and efforts to repurpose existing antibiotics • Collaboration focuses on next-generation sequencing (NGS) and AI-assisted bioinformatics solutions for surveillance and drug repurposing efforts
More info >>